NASDAQ CEO Signature Series Broadcasted From the NASDAQ MarketSite

NEW YORK, April 29, 2015 (GLOBE NEWSWIRE) -- Veteran business journalist Carmen Roberts joins Peter Leys, Executive Chairman and Director, Materialise [MTLS] to discuss the company's industry, strategy, financials and positioning.

Click here to view video: http://edge.media-server.com/m/p/m6xh8ztq

Peter Leys, Materialise [MTLS] Executive Chairman and Director

Peter Leys has served as a Director and Executive Chairman since 2013. Previously, from 1990 to 2013, Mr. Leys was at the Brussels office of Baker & McKenzie CVBA, where he focused on mergers and acquisitions, and capital markets. Mr. Leys became an International Partner of Baker & McKenzie CVBA in 1998 and was appointed Co-head of its Brussels office's corporate finance practice group in 2009. As an attorney, Mr. Leys has advised Materialise since 1997 and has assisted the company on most of its milestone corporate and commercial transactions. In 2012, Mr. Leys, who has been mentioned numerous times as a leading corporate lawyer in Chambers, Legal 500 and IFLR 1000, received the International Law Office "Client's Choice Award" for M&A in Belgium. Mr. Leys is a Fulbright fellow and lectures a mergers and acquisitions contract design course at the KULeuven University. Mr. Leys holds a Candidacy Degree in Philosophy from KULeuven and Master of Law degrees from KULeuven and the University of Georgia.

Materialise [MTLS]

With its headquarters in Leuven, Belgium, and branches worldwide, Materialise is a provider of Additive Manufacturing (AM) software solutions and sophisticated 3D printing services in a wide variety of industries, including healthcare, automotive, aerospace, art and design and consumer products. Materialise has been playing an active role in the field of AM since 1990, through its involvement in AM for industrial and medical applications, by providing biomedical and clinical solutions such as medical image processing and surgical simulations and by developing unique solutions for its customers' prototyping, production, and medical needs.



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: The NASDAQ OMX Group, Inc. via Globenewswire
HUG#1916905
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Nasdaq Charts.
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Nasdaq Charts.